Delivery Order SPE2DB22D3301-SPE2DB25FY8MF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,249.56. This firm fixed-price delivery order, which was not set-aside and competitively awarded, was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.22 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitive delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,209.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector packs (2-count). This competitively awarded, non-set-aside delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and operates under firm fixed pricing. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,096.35. This firm fixed-price delivery order, awarded April 30, 2025, with a completion date of May 1, 2025, represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.28 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by July 21, 2025. The order was issued on July 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $23,293.20 delivery order on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a discrete fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector packs (two-pack units) on June 16, 2025, with a ceiling value of $2,429.74 and ultimate completion date of June 17, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,856.40 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, firm fixed-price contract was executed on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8MFDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,665.50 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, with a completion date of July 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, medical devices, and healthcare commodities to support military healthcare programs and other federal health systems worldwide. AmerisourceBergen's pharmaceutical distribution capabilities and existing federal procurement relationships position it to fulfill critical medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/29/25 |